Tajik Zahra, Bokharaei-Salim Farah, Ghorbani Saied, Keyvani Hossein, Esghaei Maryam, Monavari Seyed Hamidreza, Ataei-Pirkooh Angila, Garshasbi Saba, Donyavi Tahereh, Fakhim Atousa
HIV Laboratory of National Center, Iran University of Medical Sciences, Tehran, Iran.
Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Arch Virol. 2018 Jun;163(6):1559-1566. doi: 10.1007/s00705-018-3740-y. Epub 2018 Feb 23.
The presence of hepatitis B virus (HBV) DNA in the absence of traceable hepatitis B surface antigen (HBsAg) in the plasma specimen of patients is defined as occult HBV infection (OBI). This study aimed to detect HBV-DNA in the plasma and peripheral blood mononuclear cells (PBMCs) of Iranian HBsAg negative patients with human immunodeficiency virus (HIV) infection. This cross-sectional study was conducted on 172 patients with HIV infection from September 2015 to August 2017. The patients were tested for serological parameters (HBsAg, HBcAb, HBeAg and HBeAb) against HBV infection. Moreover, they were tested for HBV viral load (using COBAS TaqMan 48 Kit, Roche, USA) in plasma and the presence of the HBV genome in PBMC specimens using real-time PCR. The mean age of the patients was 35.4 ± 13.4 years. Of the 172 studied patients, 109 (63.4%) were male. In this study, 151 (87.8%) patients were negative for HBsAg, 111 (64.5%) patients were negative for all HBV infection serological markers, 9 (5.2%) patients were only positive for HBsAg and 29 (16.9%) patients were only positive for HBcAb. Moreover, five (3.3%) patients with HBsAg negative had OBI (in the plasma sample of four patients and PBMC specimens of all five patients, HBV-DNA was detected). The present study revealed that 3.3% of the patients with HIV infection had occult HBV infection. Presumably, designing prospective studies to identify this infection in patients with HIV infection is informative and valuable.
患者血浆样本中存在乙型肝炎病毒(HBV)DNA但无法检测到乙型肝炎表面抗原(HBsAg),这被定义为隐匿性HBV感染(OBI)。本研究旨在检测伊朗感染人类免疫缺陷病毒(HIV)的HBsAg阴性患者血浆及外周血单个核细胞(PBMC)中的HBV-DNA。这项横断面研究于2015年9月至2017年8月对172例HIV感染患者进行。对患者进行了针对HBV感染的血清学参数检测(HBsAg、HBcAb、HBeAg和HBeAb)。此外,还检测了他们血浆中的HBV病毒载量(使用美国罗氏公司的COBAS TaqMan 48试剂盒)以及PBMC样本中HBV基因组的存在情况(使用实时PCR)。患者的平均年龄为35.4±13.4岁。在172例研究患者中,109例(63.4%)为男性。在本研究中,151例(87.8%)患者HBsAg阴性,111例(64.5%)患者所有HBV感染血清学标志物均为阴性,9例(5.2%)患者仅HBsAg阳性,29例(16.9%)患者仅HBcAb阳性。此外,5例(3.3%)HBsAg阴性患者存在OBI(在4例患者的血浆样本和所有5例患者的PBMC样本中检测到HBV-DNA)。本研究显示,3.3%的HIV感染患者存在隐匿性HBV感染。据推测,设计前瞻性研究以识别HIV感染患者中的这种感染具有参考价值。